File

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, April 10, 2024
Copper, Sickle cell disease, FDA, Cancer, Elivaldogene autotemcel, DSM-IV codes, SCD, News, Food, Truist, Blue, Complaint, Class, Barclays, Meta, History, P.C, Patient, Defendant, False, Medicare, NBH, BLA, Metamaterial, File, Biotechnology, Health, Disclosure

In return, agilon takes on the responsibility of managing the total cost and quality of care for those patients.

Key Points: 
  • In return, agilon takes on the responsibility of managing the total cost and quality of care for those patients.
  • This model incentivizes agilon and its contracted physician partners to focus on preventive care and improve health outcomes in order to control costs.
  • If the total cost of caring for patients is less than the fixed payments agilon receives, it realizes a profit.
  • On this news, agilon’s stock price fell $2.23, or 13.2 percent, to close at $14.66 on November 3, 2023.

Athena Technology Acquisition Corp. II Announces Receipt of Notice of Non-Compliance with NYSE American Continued Listing Requirements

Retrieved on: 
Wednesday, April 24, 2024
Professional Services, Finance, ATEK, Failure, File

Athena Technology Acquisition Corp. II (NYSE American: ATEK.U, ATEK, ATEK WS) (“ATEK” or the “Company”) received an official notice of noncompliance (the “NYSE American Notice”) from NYSE Regulation (“NYSE”) stating that the Company is not in compliance with NYSE American continued listing standards (the “Filing Delinquency Notification”) due to the failure to timely file the Company’s Form 10-K for the year ended December 31, 2023 (the “Delinquent Report”) by the filing due date of April 16, 2024 (the “Filing Delinquency”).

Key Points: 
  • Athena Technology Acquisition Corp. II (NYSE American: ATEK.U, ATEK, ATEK WS) (“ATEK” or the “Company”) received an official notice of noncompliance (the “NYSE American Notice”) from NYSE Regulation (“NYSE”) stating that the Company is not in compliance with NYSE American continued listing standards (the “Filing Delinquency Notification”) due to the failure to timely file the Company’s Form 10-K for the year ended December 31, 2023 (the “Delinquent Report”) by the filing due date of April 16, 2024 (the “Filing Delinquency”).
  • The Company intends, however, to regain compliance with the NYSE American continued listing standards once the Delinquent Report has been filed.
  • In the interim, the NYSE American Notice has no immediate effect on the listing or trading of the Company’s Class A common stock listed on NYSE American.
  • There can be no assurance that the Company will ultimately regain and remain in compliance with all applicable NYSE American listing standards.

Siebert Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

Retrieved on: 
Wednesday, April 24, 2024
Banking, Accounting, Professional Services, Finance, Annual report, Security (finance), Communication, Notice, File, Calendar, Cryptocurrency

Based on discussions with the Company’s auditors, the Company expects to file its 2023 10-K with an unqualified audit opinion before the prescribed due date to comply with the Nasdaq Listing Rule for continued listing.

Key Points: 
  • Based on discussions with the Company’s auditors, the Company expects to file its 2023 10-K with an unqualified audit opinion before the prescribed due date to comply with the Nasdaq Listing Rule for continued listing.
  • The Notice has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq.
  • Nasdaq has provided the Company with 60 calendar days, until June 17, 2024, to submit a plan to regain compliance.
  • If Nasdaq accepts the Company's plan, then Nasdaq may grant the Company up to 180 days from the prescribed due date for the filing of the 2023 10-K, or October 14, 2024, to regain compliance.

EPI Health, LLC Issues Voluntary Recall

Retrieved on: 
Tuesday, April 23, 2024
Health, Pharmaceutical, Online, FDA, Bankruptcy, Chapter Seven, File, Patient, Knowledge, Novin, Food

The EPI Health/Novan Trustee is initiating a voluntary recall of various within-expiry human drug products (Attachment 1) as a result of the closures and discontinuation of the post-marketing quality, regulatory and pharmacovigilance activities for these marketed products.

Key Points: 
  • The EPI Health/Novan Trustee is initiating a voluntary recall of various within-expiry human drug products (Attachment 1) as a result of the closures and discontinuation of the post-marketing quality, regulatory and pharmacovigilance activities for these marketed products.
  • EPI Health has not received any reports of adverse events related to this recall.
  • EPI Health, LLC is notifying its distributors and direct consignees by direct mailing and is requesting they further notify their customers/consumers/retailers.
  • Consumers with questions regarding this recall can contact EPI Health at Phone: 888-671-8858 during normal business hours (8am – 5pm CDT) Monday – Friday or thru email at [email protected] .

Capstone Green Energy Announces Mark Funaki as its General Counsel

Retrieved on: 
Monday, April 22, 2024
Alternative Energy, Energy, Utilities, Corporation, Public policy, Capstone, General counsel, Annual report, Culture, Duke University, Vanderbilt University Law School, Senior, CUSIP, File, Management

Capstone Green Energy Holdings, Inc. (the “Company”), the public successor to Capstone Green Energy Corporation (Predecessor Capstone), is pleased to announce that Mark Funaki has been appointed as the Company’s General Counsel and Corporate Secretary.

Key Points: 
  • Capstone Green Energy Holdings, Inc. (the “Company”), the public successor to Capstone Green Energy Corporation (Predecessor Capstone), is pleased to announce that Mark Funaki has been appointed as the Company’s General Counsel and Corporate Secretary.
  • Prior to joining Capstone, Mark held roles of increasing responsibility at Jafra Cosmetics International, Inc., culminating with the position of Senior Vice President and General Counsel.
  • We welcome Mark and his acumen to the Capstone family,” said Vince Canino, Capstone’s President and Chief Executive Officer.
  • “I am honored to join Capstone and eager to contribute to the Company’s continued success,” said Mark Funaki.

KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors

Retrieved on: 
Monday, April 22, 2024
Biotechnology, Pharmaceutical, Health, Clinical Trials, FDA, University, KALV, Therapy, Hereditary angioedema, Actelion, Warner–Lambert, Parke-Davis, File, Pharmaceutical industry

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that William C. Fairey has been appointed to the Company’s Board of Directors, effective immediately.

Key Points: 
  • KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that William C. Fairey has been appointed to the Company’s Board of Directors, effective immediately.
  • Mr. Fairey was most recently the Chief Commercial Officer at MyoKardia, Inc., a clinical stage biopharmaceutical company, and is a business leader with significant experience building markets and launching novel therapeutics to treat specialty and rare/orphan diseases.
  • “We welcome Bill to our Board of Directors,” said Ben Palleiko, CEO of KalVista.
  • Mr. Fairey received his M.B.A. from St. Mary’s College of California and his B.S.

Momentus Receives Nasdaq Deficiency Notification Regarding Delayed Form 10-K

Retrieved on: 
Monday, April 22, 2024
Engineering, Defense, Technology, Consumer, Other Retail, Aerospace, Manufacturing, Mobile, Wireless, Other Energy, Retail, Satellite, Alternative Energy, Energy, Science, Other Transport, Automotive, Other Consumer, Transport, Other Science, Other Manufacturing, Other Defense, Contracts, Notice, Form, Commission, Form 10-K, Inc., Bank statement, File, Calendar, Cryptocurrency

The Notice has no immediate impact on the listing of the Company’s common stock on Nasdaq, and the Company’s listing remains fully effective.

Key Points: 
  • The Notice has no immediate impact on the listing of the Company’s common stock on Nasdaq, and the Company’s listing remains fully effective.
  • The Company has 60 calendar days from the date of the Notice, or until June 17, 2024, to file the Form 10-K or to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rule 5250(c)(1).
  • If the Company submits a plan to Nasdaq and Nasdaq accepts the plan, Nasdaq can grant an exception of up to 180 calendar days from the due date of the filing of the Form 10-K, or until October 14, 2024, to regain compliance.
  • If the Company does not regain compliance within the allotted compliance periods, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s common stock will be subject to delisting.

Slate Office REIT Provides Update on Resignation of Trustee and Nomination of Trustees at Upcoming Annual Meeting of Unitholders

Retrieved on: 
Saturday, April 20, 2024
Commercial Building & Real Estate, Construction & Property, REIT, Slate, Meeting, TSX, Compensation, Trustee, Proxy, Notice, Committee, Trust, Name, File, Security (finance)

In February 2023, the REIT entered into a settlement agreement with G2S2 Capital Inc. (“G2S2”), the sole shareholder of Armco Alberta Inc. (“Armco”), both entities affiliated with current trustee George Armoyan.

Key Points: 
  • In February 2023, the REIT entered into a settlement agreement with G2S2 Capital Inc. (“G2S2”), the sole shareholder of Armco Alberta Inc. (“Armco”), both entities affiliated with current trustee George Armoyan.
  • Since the date of the initial settlement agreement, the nominees of G2S2 have continued to be George Armoyan and Jean-Charles Angers.
  • Accordingly, the REIT Circular delivered to unitholders prior to the date hereof included such slate for consideration by the unitholders.
  • Mr. Dorsey has consented to being nominated by the REIT and acting as a trustee of the REIT, if elected at the Meeting.

Faraday Future Receives Letter from Nasdaq Regarding Form 10-K Filing

Retrieved on: 
Saturday, April 20, 2024
Software, Internet, EV, Electric Vehicles, Alternative Vehicles, Fuels, Automotive, Artificial Intelligence, Technology, Vehicle Technology, Form, Form 10-K, File, Calendar, Letter, Cryptocurrency

Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global shared intelligent electric mobility ecosystem company, today announced that it received a letter (the “Nasdaq Letter”) from The Nasdaq Stock Market (“Nasdaq”) dated April 18, 2024, indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1).

Key Points: 
  • Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global shared intelligent electric mobility ecosystem company, today announced that it received a letter (the “Nasdaq Letter”) from The Nasdaq Stock Market (“Nasdaq”) dated April 18, 2024, indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1).
  • The Nasdaq Letter was issued in accordance with standard Nasdaq procedures due to the delayed filing of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”).
  • The Nasdaq Letter further advised the Company that it will be placed on a list of non-compliant Nasdaq companies beginning five business days after April 18, 2024.
  • Upon the Company’s filing of its Form 10-K and any subsequent period filing that will be due within the 180-day period referenced above, the Company will again become compliant with Nasdaq Marketplace Rule 5250(c)(1).

Tijuana Flats Announces Ownership Change

Retrieved on: 
Friday, April 19, 2024
Retail, Restaurant, Bar, Food, Beverage, Sale, Health, TJF, Serving size, File

Central Florida-based Tijuana Flats (TF) announced today that a new ownership group has acquired the brand with a plan of revitalizing its restaurants and reinvigorating the customer experience.

Key Points: 
  • Central Florida-based Tijuana Flats (TF) announced today that a new ownership group has acquired the brand with a plan of revitalizing its restaurants and reinvigorating the customer experience.
  • Prior to the change of ownership this month, Tijuana Flats had been owned by TJF USA, LLC.
  • Joe Christina, Chief Executive Officer of Tijuana Flats, said, “Our company is excited by the new ownership group’s plan to reinvest, focus, and emphasize the things that originally brought so many people to love Tijuana Flats.
  • Tijuana Flats will continue to provide full support to its franchisees and its remaining locations will continue to operate as usual.